Processes
Validate targets
How validate targets are reshaped as AGI capability advances.
ProcessesValidate targets
Business-as-Code
Read as an executable program — the work decomposed into Code, Generative, Agentic, and Human.
Validate targets sits inside a larger value-flow — 1 parent structure it composes into. The hierarchy is grounding, not the story: it tells you which aggregate exposure Validate targets inherits.
Where Validate targets sits
Related articles
No articles yet for this entity.
Recent capability events
No capability events for this entity yet.
How the work flows
Trigger: A preliminary biological target, such as a gene or protein associated with a disease, is nominated from early discovery efforts.
- Receive nominated biological targets from the discovery phase
- Conduct genetic and biochemical assays to test disease correlation
- Perform in vitro and in vivo experiments to confirm target engagement
- Assess preliminary safety and toxicity risks of target modulation
- Analyze validation data to determine therapeutic potential
- Approve or reject the target for lead compound screening
Outcome: The biological target is definitively confirmed as viable for therapeutic intervention or rejected due to lack of efficacy or safety.
Measured by
Target Validation Success RateValidation Cycle TimeCost Per Validated Target